Gyre Therapeutics Inc. – Filings and Transcripts

NASDAQ: GYRE
Share price (9/29/26): $7.32
Market cap (9/29/26): $816 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration – amended

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Carmichael Gordon

News Filter

Investor Presentation

Investor Presentation

Reports Second Quarter 2026 and Year-To-Date Financial Results and Provides Business Update

Appoints Three New Members to Its Board of Directors

Report of Independent Registered Public Accounting Firm

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC